Welcome to LookChem.com Sign In|Join Free

CAS

  • or

119421-28-2

Post Buying Request

119421-28-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

119421-28-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 119421-28-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,4,2 and 1 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 119421-28:
(8*1)+(7*1)+(6*9)+(5*4)+(4*2)+(3*1)+(2*2)+(1*8)=112
112 % 10 = 2
So 119421-28-2 is a valid CAS Registry Number.

119421-28-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-morpholin-4-ylbenzene-1,2-diamine

1.2 Other means of identification

Product number -
Other names 4-morpholinobenzene-1,2-diamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:119421-28-2 SDS

119421-28-2Relevant articles and documents

Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors

Chen, Ting,Sorna, Venkataswamy,Choi, Susie,Call, Lee,Bearss, Jared,Carpenter, Kent,Warner, Steven L.,Sharma, Sunil,Bearss, David J.,Vankayalapati, Hariprasad

, p. 5473 - 5480 (2017)

In this work, we describe the use of the rule of 3 fragment-based strategies from biochemical screening data of 1100 in-house, small, low molecular weight fragments. The sequential combination of in silico fragment hopping and fragment linking based on S1

SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

-

, (2021/04/01)

The invention provides substituted benzimidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.

NEW QUINOLINONE COMPOUNDS

-

Page/Page column 73, (2019/01/17)

Provided are new quinolinone compounds, pharmaceutical compositions comprising said compounds, processes for the preparation of said compounds and the use of said compounds as FGFR inhibitors and their use in the treatment of diseases, e.g. cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 119421-28-2